Health Inequities in Inflammatory Bowel Disease CarePremiere Date: Monday, November 21, 2022
This activity offers CE credit for:%>
- ABIM (MOC)
- ABS (CC)
- Medicine (accme)
- Nursing (ANCC)
- Pharmacy (acpe)
- PA (aapa)
- Dietetic Registration (CDR)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Friday, November 21, 2025
|Monica E. Peek, MD, MPH, MSc (Moderator)
Ellen H. Block Professor of Health Justice in the Department of Medicine
Associate Director, Chicago Center for Diabetes Translation Research
Director of Research, MacLean Center for Clinical Medical Ethics
The University of Chicago
|Sophie Balzora, MD, FACG
Clinical Associate Professor of Medicine
NYU Grossman School of Medicine
Division of Gastroenterology and Hepatology
NYU Langone Health
New York, NY
|Nana Bernasko, CRNP, DNP, WHNP-BC
Assistant Professor of Medicine
Division of Gastroenterology and Hepatology
Penn State Hershey Medical Center
The incidence of inflammatory bowel disease (IBD) is increasing in all patient groups but rates are rising fastest in non-Hispanic Black patients. Clinicians are failing to recognize IBD in these high- incidence populations, leading to delays in diagnosis and worse long-term outcomes. Inequities in preventative care, health care worker bias, and social determinants of health (SDoH) are all barriers to the prompt recognition of IBD and achieving the best possible outcomes in IBD care.
Specific steps must be taken to achieve equitable IBD care. All health care staff members should be included in diversity and inclusion training efforts and education to address unconscious bias. Practicing U.S. gastroenterologists are not representative of the population they care for and concerted efforts are needed to improve diversity, starting with undergraduate trainees interested in gastroenterology.
In this podcast installment of a multi-prong diversity, equity, and inclusion (DEI) series, Monica E. Peek, MD, MPH, MSc; Sophie Balzora, MD, FACG; and Nana Bernasko, CRNP, DNP, WHNP-BC, will discuss strategies vital to combating inequities in IBD. The conversation will describe modern-day issues in how unconscious bias, health disparities, and health inequities all influence quality of care, and will provide real-world strategies to improve IBD care for all patients.
At the end of this CE activity, participants should be able to:
- Analyze the influence of unconscious bias, health disparities, and health inequities on the care of patients with inflammatory bowel disease.
Supported by an educational grant from Johnson & Johnson.
Physicians, PAs, NPs, nurses, pharmacists, and dieticians specializing in gastroenterology, surgery, primary care, or internal medicine.
ABIM MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Learning formats: Enduring material
Royal College MOC:
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
MIPS Improvement Activity: This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
ABPN Diplomates may select any CME activity relevant to their practice to count towards ABPN MOC requirements.
Dr. Peek reports the following financial relationships:
Consultant: Pfizer Inc.
Dr. Balzora reports the following financial relationships:
Advisory Board: Janssen Pharmaceuticals, Inc. and Pfizer Inc.
Consultant: AbbVie Inc.
Dr. Bernasko reports the following financial relationships:
Advisory Board: AbbVie Inc.; Boehringer Ingelheim GmbH; Bristol Myers Squibb Company; Eli Lilly and Company; and Janssen Pharmaceuticals, Inc.
Speakers Bureau: AbbVie Inc.; Bristol Myers Squibb Company; and Janssen Pharmaceuticals, Inc.
The following peer reviewer and CME Outfitters staff have no financial relationships:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).